Skip to main content
SpringerLink
Log in

Hepatitis B Virus Transgenic Mice: Models of Viral Immunobiology and Pathogenesis

  • Chapter
Transgenic Models of Human Viral and Immunological Disease

Part of the book series: Current Topics in Microbiology and Immunology ((CT MICROBIOLOGY,volume 206))

Abstract

The hepatitis B virus (HBV) is a noncytopathic, enveloped virus with a circular, double-stranded DNA genome that causes acute and chronic necroinflammatory liver disease and hepatocellular carcinoma (reviewed in CHISARI and FERRARI 1994). HBV infection acquired in adult life is often clinically inapparent and the vast majority of acutely infected adults recover completely from the disease and clear the virus. Rarely, however, the acute liver disease may be so severe that the patient can die from fulminant hepatitis. Approximately 5%–10% of acutely infected adults become persistently infected by the virus and develop chronic liver disease of varying severity. Neonatally transmitted HBV infection, however, is rarely cleared, and over 90% of such children become chronically infected. Because HBV is commonly spread from infected mother to newborn infant in highly populated areas of Africa and Asia, several hundred million people throughout the world are persistently infected by HBV for most of their lives and suffer varying degrees of chronic liver disease which greatly increases their risk of developing cirrhosis and hepatocellular carcinoma (HCC). Indeed, the risk of HCC is increased 100-fold in patients with chronic hepatitis, and the lifetime risk of HCC in males infected at birth approaches 40% (BEASLEY ET AL. 1981). Accordingly, a large fraction of the world’s population suffers and dies from these late complications of HBV infection.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 16.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Alexander GJ, Eddieston AL (1986) Does maternal antibody to core antigen prevent recognition of transplacental transmission of hepatitis-B-virus infection2. Lancet 1: 296–297

    Article  PubMed  CAS  Google Scholar 

  • Alter HJ (1988) Transfusion-associated non-A, non-B hepatitis: the first decade. In: Zuckerman AJ (ed) Viral hepatitis and liver disease. Liss, New York, pp 534–

    Google Scholar 

  • Ando K, Moriyama T, Guidotti LG, Wirth S, Schreiber RD, Schlicht HJ, Huang S, Chisari FV (1993) Mechanisms of class I restricted immunopathology. A transgenic mouse model of fulminant hepatitis. J Exp Med 178: 1541–1554

    Article  PubMed  CAS  Google Scholar 

  • Ando K, Guidotti LG, Cerny A, Ishikawa T, Chisari FV (1994a) CTL access to tissue antigen is restricted in vivo. J Immunol 153: 482–488

    PubMed  CAS  Google Scholar 

  • Ando K, Guidotti LG, Wirth S, Ishikawa T, Missale G, Moriyama T, Schreiber RD, Schlicht HJ, Huang S, Chisari FV (1994b) Class I restricted cytotoxic T lymphocytes are directly cytopathic for their target cells in vivo. J Immunol 152: 3245–3253

    PubMed  CAS  Google Scholar 

  • Araki K, Miyazaki J-I, Hino O, Tomita N, Chisaka O, Matsubara K, Yamamura K-I (1989) Expression and replication of hepatitis B virus genome in transgenic mice. Proc Natl Acad Sci USA 86: 207–211

    Article  PubMed  CAS  Google Scholar 

  • Babinet C, Farza H, Morello D, Hadchouel M, Pourcel C (1985) Specific expression of hepatitis B surface antigen (HBsAg) in transgenic mice. Science 230: 1160–1163

    Article  PubMed  CAS  Google Scholar 

  • Bartenschlager R, Junker-Niepmann M, Schaller H (1990) The P gene product of hepatitis B virus is required as a structural component for genomic RNA encapsidation. J Virol 64: 5324–5332

    PubMed  CAS  Google Scholar 

  • Bavand MR, Laub O (1988) Two proteins with reverse transcriptase activities associated with hepatitis B virus-like particles. J Virol 62: 626–628

    PubMed  CAS  Google Scholar 

  • Bavand Mr, Feitelson M, Laub O (1989) The hepatitis B virus-associated reverse transcriptase is encoded by the viral pol gene. J Virol 63: 1019–1021

    PubMed  CAS  Google Scholar 

  • Beasley RP, Lin C-C, Hwang LY, Chen C-S (1981) Hepatocellular carcinoma and hepatitis B virus: a prospective study of 22, 707 men in Taiwan. Lancet 2: 1129–1133

    Article  PubMed  CAS  Google Scholar 

  • Blum HE, Zhang Z-S, Galun E, von Weizsäcker F, Garner B, Liang TJ, Wands JR (1992) Hepatitis B virus X protein is not central to the viral life cycle in vitro. J Virol 66: 1223–1227

    PubMed  CAS  Google Scholar 

  • Bosch V, Bartenschlager R, Radziwill G, Schaller H (1988) The duck hepatitis B virus P-gene codes for protein strongly associated with the 5’-end of the viral DNA minus strand. Virology 166

    Google Scholar 

  • Burk RD, DeLoia JA, ElAwady MK, Gearhart JD (1988) Tissue preferential expression of the hepatitis B virus (HBV) surface antigen gene in two lines of HBV transgenic mice. J Virol 62: 649–654

    PubMed  CAS  Google Scholar 

  • Carlson J, Eriksson S (1985) Chronic “cryptogenic” liver disease and malignant hepatoma in intermediate alpha-1-antitrypsin deficiency identified by a pi 2-specific monoclonal antibody. Scand J Gastroenterol 20: 835–841

    Article  PubMed  CAS  Google Scholar 

  • Chemin I, Baginski I, Vermot-Desroches C, Hantz O, Jacquet C, Rigal D, Trepo C (1992) Demonstration of woodchuck hepatitis virus infection of peripheral blood mononuclear cells by flow cytometry and polymerase chain reaction. J Gen Virol 73: 123–129

    Article  PubMed  CAS  Google Scholar 

  • Chen HS, Knew MC, Hornbuckle WE, Tenant BC, Cote PJ, Gerin JL, Purcell RH, Miller RH (1992) The precore gene of the woodchuck hepatitis virus genome is not essential for viral replication in the natural host. J Virol 66: 5682–5684

    PubMed  CAS  Google Scholar 

  • Chen HS, Kaneko S, Girones R, Anderson RW, Hornbuckle WE, Tenant BC, Cote PJ, Gerin JL, Purcell RH, Miller RH (1993) The woodchuck hepatitis virus X gene is important for establishment of virus infection in woodchucks. J Virol 67: 1218–1226

    PubMed  CAS  Google Scholar 

  • Chen HS, Kaneko S, Girones R, Anderson RW, Hornbuckle WE, Tennant BC, Cote PJ, Gerin JL, Purcell RH, Miller RH (1994) The woodchuck hepatitis virus X gene is important for establishment of virus infection in woodchucks. J Virol 67: 1218–1226

    Google Scholar 

  • Chisari FV (1991) Analysis of hepadnavirus gene expression, biology and pathogenesis in the transgenic mouse. Curr Top Microbiol Immunol 168: 85–101

    PubMed  CAS  Google Scholar 

  • Chisari FV, Ferrari C (1994) Immunobiologyand pathogenesis of viral hepatitis. In: Nathenson N Ahmed R, Gonzatez-Scarano F, Griffin D, Holmes K, Murphy FA, Robinson H (eds) Viral pathogenesis. Raven New York, (in press)

    Google Scholar 

  • Chisari FV, Pinkert CA, Milich DR, Filippi P, McLachlan A, Palmiter RD, Brinster RL (1985) A transgenic mouse model of the chronic hepatitis B surface antigen carrier state. Science 230: 1157–1160

    Article  PubMed  CAS  Google Scholar 

  • Chisari FV, Filippi P, McLachlan A, Milich DR, Riggs M, Lee S, Palimiter RD, Pinker CA, Brinster RL (1986) Expression of hepatitis B virus large envelope polypeptide inhibits hepatitis B surface antigen secretion in transgenic mice. J Virol 60: 880–887

    PubMed  CAS  Google Scholar 

  • Chisari FV, Filippi P, Buras J, MclLlachlan A, Popper H, Pinkert CA, Palmiter RD, Brinstaer RL (1987) Structural and pathological effects of synthesis of hepatitis B virus large envelope polypeptide in transgenic mice. Proc Natl Acad Sci USA 84: 6909–6913

    Article  PubMed  CAS  Google Scholar 

  • Chisari FV, Klopchin K, Moriyama T, Pasquinelli C, Dunsford HA, Sell S, Pinkert CA, Brinster RL, Palmiter RD (1989) Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice. Cell 59: 1145–1156

    Article  PubMed  CAS  Google Scholar 

  • Colgrove R, Simon G, Ganem D (1989) Transcriptional activation of homologous and heterologous genes by the hepatitis B virus X gene product in cells permissive for viral replication. J Virol 63: 4019–4026

    PubMed  CAS  Google Scholar 

  • Condreay LD, Aldrich CE, Coates L, Mason WS, Wu T-T (1990) Efficient duck hepatitis B virus production by an avian liver tumor cell line. J Virol 64: 3249–3258

    PubMed  CAS  Google Scholar 

  • Cote PJ, Korba BE, Steinberg H, Ramirez-Mejia C, Baldwin B, Hornbuckle WE, Tennant BC, Gerin JL (1991) Cyclosporin A modulates the course of woodchuck hepatitis virus infection and induces chronicity. J Immunol 146: 3138–3144

    PubMed  CAS  Google Scholar 

  • DeLoia JA, Burk RD, Gearhart JD (1989) Developmental regulation of hepatitis B surface antigen expression in two lines of hepatitis B virus transgenic mice. J Virol 63: 4069–4073

    Google Scholar 

  • Dunsford HA, Sell S, Chisari FV (1990) Hepatocarcinogenesis due to chronic liver cell injury in hepatitis B virus transgenic mice. Cancer Res 50: 3400–3407

    PubMed  CAS  Google Scholar 

  • Dycaico MJ, Grant SG, Felts K, Nichols WS, Geller SA, Hager JH, Pollard AJ, Kohler SW, Short HP, Jirik FR et al. (1988) Neonatal hepatitis induced by alpha 1-antitrypsin: a transgenic mouse model. Science 242: 1409–1412

    Article  PubMed  CAS  Google Scholar 

  • Eble BE, Lingappa VR, Ganem D (1986) Hepatitis B surface antigen: an unusual secreted protein initially synthesized as a transmembrane polypeptide. Model Cell Biol 6: 1454–1463

    CAS  Google Scholar 

  • Eble BE, MacRae DR, Lingappa VR, Ganem D (1987) Multiple topogenic sequences determine the transmembrane orientation of hepatitis B surface antigen. Mol Cell Biol 7: 3591–3601

    PubMed  CAS  Google Scholar 

  • Eckhardt SG, Milich DR, McLachlan A (1991) Hepatitis B virus core antigen has two nuclear localization sequences in the arginine-rich carboxyl terminus. J Virol 65: 575–582

    PubMed  CAS  Google Scholar 

  • Eriksson S, Carlson J, Velez RN (1986) Risk of cirrhosis and primary liver cancer in alpha-1-antrypsin deficiency. N Engl J Med 314: 736–740

    Article  PubMed  CAS  Google Scholar 

  • Etiemble J, Degott C, Renard CA, Fourel G, Shamoon B, Vitvitski-Trepo L, Hsu TY, Tiollais P, Babinet C, Buendia MA (1994) Liver-specific expression and high oncogenic efficiency of a c-myc transgene activated by woodchuck hepatitis virus insertion. Oncogene 9: 727–737

    PubMed  CAS  Google Scholar 

  • Farza H, Salmon AM, Hadchouel M, Moreau, Babinet C, Tiollais P, Pourcel C (1987) Hepatitis B surface antigen gene expression is regulated by sex steroids and glucocorticoids in transgenic mice. Proc Natl Acad Sci USA 84: 1187–1191

    Article  PubMed  CAS  Google Scholar 

  • Farza H, Hadchouel M, Scotto J, Tiollais P, Babinet C, Pourcel C (1988) Replication and gene expression of hepatitis B virus in a transgenic mouse that contains the complete viral genome. J Virol 62: 4144–4152

    PubMed  CAS  Google Scholar 

  • Filippi P, Buras J, McLachlan A, Popper H, Pinkert CA, Palmiter RD, Brinster RL, Chisari FV (1988) Overproduction of hepatitis B virus large envelope polypeptide causes filament storage, ground glass cell formation, hepatocellular injury and nodular hyperplasia in transgenic mice, In: Zucker-man AJ (ed) Viral hepatitis and liver disease. Liss, New York, PP 632–

    Google Scholar 

  • Franco A, Paroli M, Testa U, Benvenuto R, Peschle CM, Balsano F, Bamaba V (1992) Transferrin receptor mediates uptake and presentation of hepatitis B envelope antigen by T lymphocytes. J Exp Med 175: 1195–1205

    Article  PubMed  CAS  Google Scholar 

  • Fukuda R, Okinaga S, Akagi S, Hidaka M, Ono N, Fukumoto S, Shimada Y (1988) Alteration of infection pattern of duck hepatitis B virus by immunomodulatory drugs. J Med Virol 26: 387–396

    Article  PubMed  CAS  Google Scholar 

  • Gerber MA, Hadziyannis S, Vissoulis C, Schaffner F, Paronetto F, Popper H (1974a) Hepatitis B antigen: nature and distribution of cytoplasmic antigen in hepatocytes of carriers (37912). Proc Soc Exp Biol Med 145: 863–867

    PubMed  CAS  Google Scholar 

  • Gerber MA, Hadziyannis S, Vissoulis C, Schaffner F, Paronetto F, Popper H (1974b) Electron microscopy and immunoelectron microscopy of cytoplasmic hepatitis B antigen in hepatocytes. Am J pathol 175: 489–502

    Google Scholar 

  • Gilles PN, Fey G, Chisari FV (1992a) Tumor necrosis factor-alpha negatively regulates hepatitis B virus gene expression in transgenic mice. J Virol 66: 3955–3960

    PubMed  CAS  Google Scholar 

  • Gilles PN, Guerrette DL, Ulevitch RJ, Schreiber RD, Chisari FV (1992b) Hepatitis B surface antigen retention sensitizes the hepatocyte to injury by physiologic concentrations of gamma interferon. Hepatology 16: 655–663

    Article  PubMed  CAS  Google Scholar 

  • Guidotti LG, Ando K, Hobbs MV, Ishikawa T, Runkel RD, Schreiber RD, Chisari FV (1994a) Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mechanism in transgeneic mice. Proc Natl Acad Sci USA 91: 3764–3768

    Article  PubMed  CAS  Google Scholar 

  • Guidotti LG, Guilhot S, Chisari FV (1994b) Interleukin 2 and interferon alpha/beta downregulate hepatitis B virus gene expression in vivo by tumor necrosis factor dependent and independent pathways. J Virol 68: 1265–1270

    PubMed  CAS  Google Scholar 

  • Guidotti LG, Martinez V, Loh YT, Rogler CE, Chisari FV (1994c) Hepatitis B virus nucleocapsid particles do not cross the hepatocyte nuclear membrane in transgenic mice. J Virol 68: 5469–5475

    PubMed  CAS  Google Scholar 

  • Guilhot S, Guidotti LG, Chisari FV (1993) lnterleukin-2 downregulates hepatitis B virus gene expression in transgenic mice by a post-transcriptional mechanism. J Virol 67: 7444–7449

    PubMed  CAS  Google Scholar 

  • Guilhot S, Huang S, Xia YP, LaMonica N, Lai MMC, Chisari FV (1994) Expression of the hepatitis delta virus and small antigens in transgenic mice. J Virol 68: 1052–1058

    PubMed  CAS  Google Scholar 

  • Hagen TM, Wehr C, Huang SN, Fowler P, Martine ZV, Curnutte J, Anes BN, Chisari FV (1994) Extensive oxidative DNA damage in hepatocytes of transgenic mice with chronic active hepatitis destined to develop hepatocellular carcinoma. Proc Natl Acad Sci USA 97: 12808–12812

    Article  Google Scholar 

  • Haritanin H, Uchida T, Okuda Y, Shikata T (1989) Effect of 3′-azido-3-deoxythmidine on replication of duck B virus in vivo and in vitro. J Med Virol 29: 244–248

    Article  Google Scholar 

  • Hertogs K, Lenders WPJ, Depla E, DeBruin WCC, Meheus L, Raymackers J, Moshage H, Yap SH (1993) Endonexin II, present on human liver plasma membranes, is a specific binding protein of small hepatitis B virus envelope protein. Virology 197: 549–557

    Article  PubMed  CAS  Google Scholar 

  • Hino O, Nomura K, Ohtake K, Kawaguchi T, Sugano H, Kitagawa T (1989) Instability of integrated hepatitis B virus DNA with inverted repeat structure in a transgenic mouse. Cancer Genet Cytogenet 37: 273–278

    Article  PubMed  CAS  Google Scholar 

  • Hirsch RC, Lavine JE, Chang L, Varmus HE, Ganem D (1990) Polymerase gene products of hepatitis B viruses are required for genomic RNA packaging as well as for reverse transcription. Nature 344: 552–555

    Article  PubMed  CAS  Google Scholar 

  • Höhne M, Schaefer S, Seifer M, Feitelson MA, Paul D, Gerlich WH (1990) Malignant transformation of immortalized transgenic hepatocytes after transfection with hepatitis B virus DNA. EMBO J 9: 1137–1145

    PubMed  Google Scholar 

  • Homburger F, Russfield AB, Weisburger JH, Lim S, Chak SP, Weisburger EK (1975) Aging changes in CD1 HaM/ICR mice reared under standard laboratory conditions. J Natl Cancer Inst 55: 37–45

    PubMed  CAS  Google Scholar 

  • Jean-Jean O, Weimer T, De Recondo AM, Will H, Rossignol JM (1989) Internal entry of ribosomes and ribosomal scanning involved in hepatitis B virus P gene expression. J Virol 63: 5451–5454

    PubMed  CAS  Google Scholar 

  • Jilbert AR, Wu T-T, England JM, De La M, Hall P, Carp NZ, O’Connell AP, Mason WS (1992) Rapid resolution of duck hepatitis B virus infections occurs after massive hepatocellular involvement. J Virol 66: 1377–1388

    PubMed  CAS  Google Scholar 

  • Junker-Niepmann M, Bartechlager R, Schaller H (1990) A short cis-acting sequence is required for hepatitis B virus progenome encapsidation and sufficient for packaging of foreign RNA. EMBO J 9: 3389–3396

    PubMed  CAS  Google Scholar 

  • Kawamoto S, Yamamoto S, Ueda K, Nagahata T, Chisaka O, Matsubara K, (1990) Translation of hepatitis B virus DNA polymerase from the internal AUG codon, not from the upstream AUG codon for the core protein. Biochem Biophys Res Commun 171: 1130–1136

    Article  PubMed  CAS  Google Scholar 

  • Kim C-M, Koike K, Saito I, Miyamura T, Jay G (1991) HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature 351: 317–320

    Article  PubMed  CAS  Google Scholar 

  • Koike K, Moriya K, lino S, Yotsuyanagi H, Endo Y, Miyammura T, Hurokawa K (1994) High level expression of hepatitis B virus HBx gene and hepatocarcinogenesis in transgenic mice. Hepatology. 19: 810–819

    Article  PubMed  CAS  Google Scholar 

  • Korba BE, Wells F, Tennant BC, Yoakum GH, Purcell RH, Gerin JL (1986) Hepadnavirus infection of peripheral blood lymphocytes in vivo: woodchuck and chimpanzee models of viral hepatitis. J Virol 58: 1–8

    PubMed  CAS  Google Scholar 

  • Korba BE, Wells F, Tennant BC, Cote PJ, Gerin JL (1987) Lymphoid cells in the spleens of woodchuck hepatitis virus-infected woodchucks are a site of active viral replication. J Virol 61: 1318–1324

    PubMed  CAS  Google Scholar 

  • Korba BE, Cote PJ, Wells FV, Baldwin B, Popper H, Purcell RH, Tennant BC, Gerin JI (1989) Natural history of woodchuk hepatitis virus infections during the course of experimental viral infection: molecular virologie features of the liver and lymphoid tissues. J Virol 63: 1360–1370

    PubMed  CAS  Google Scholar 

  • Korba BE, Brown TL, Wells FV, Baldwin B, Cote PJ, Steinberg H, Tennant BC, Gerin JL (1990) Natural history of experimental woodchuck hepatitis virus infection: molecular virologie features of the pancreas, kidney, ovary, and testis. J Virol 64: 4499–4506

    PubMed  CAS  Google Scholar 

  • Kuo MT, Zou J-Y, Teeter LD, Ikeguchi M, Chisari FV (1992) Activation of multidrug resistance (P-glycoptotein) mdr3/mdrla gene during the development of hepatocellular carcinoma in hepatitis B virus transgenic mice. Cell Growth Differ 3: 531–540

    PubMed  CAS  Google Scholar 

  • Lavine J, Hirsch R (1989) A system for studying the selective encapsidation of hepadnavirus FNA. J Virol 63: 4257–4263

    PubMed  CAS  Google Scholar 

  • Lee T-H, Finegold MJ, Shen R-F, DeMayo JL, Woo SL, Butel JS (1990) Hepatitis B virus transactivator X protein is not tumorigenic in transgenic mice. J Virol 64: 5939–5947

    PubMed  CAS  Google Scholar 

  • Lieber CS, Garro A, Leo MA, Mak KM, Worner T (1986) Alcohol and cancer. Hepatology 6: 1005–1019

    Article  PubMed  CAS  Google Scholar 

  • Lien J-M, Aldrich CE, Mason WS (1986) Evidence that a capped oligoribonucleotide is the primer for duck hepatitis B virus plus-strand DNA synthesis. J Virol 57: 229–236

    PubMed  CAS  Google Scholar 

  • Limmer J, Fleig WE, Leupold D, Bittner R, Ditscheunest H, Berger H-G (1988) Hepatocellular carcinoma in type 1 glycogen storage disease. Hepatology 8: 531–537

    Article  PubMed  CAS  Google Scholar 

  • Machida A, Kishimoto S, Ohnuma H, Miyamoto H, Baba K, Oda K, Nakamura T, Miyakawa Y, Mayumi M (1983) A hepatitis B surface antigen polypeptide (P31) with the receptor for polymerized human as well as chimpanzee albumins. Gastroenterology 85: 268–274

    PubMed  CAS  Google Scholar 

  • Mack DH, Bloch W, Nath N, Sninsky JJ (1988) Hepatitis B virus particles contain a polypeptide encoded by the largest open reading frame: a putative reverse transcriptase. J Virol 62: 4768–4790

    Google Scholar 

  • Maguire HF, Hoeffler JP, Siddiqui A (1991) HBV X protein alters the DNA binding specificity of CREB and ATF-2 by protein-protein interactions. Science 252: 842–844

    Article  PubMed  CAS  Google Scholar 

  • Mancini M, Hadchouel M, Tiollais P, Pourcel C, Michel ML (1993) Induction of anti-hepatitis B surface antigen (HBsAg) antibodies in HBsAg producing transgenic mice: a possible way of circumventing “nonresponse” to HBsAg. J Med Virol 39: 67–74

    Article  PubMed  CAS  Google Scholar 

  • Marion PL, Oshiro LS, Regnery DC, Scullard GH, Robinson WS (1980) A virus in Beechey ground squirrels which is related to hepatitis B virus of man. Proc Natl Acad Sci USA 77: 2941–2945

    Article  PubMed  CAS  Google Scholar 

  • Marion PL, Van Davelaar MJ, Knight SS, Salazar FH, Garcia G, Popper H, Robinson WS (1986) Hepatocellular carcinoma in ground squirrels persistently infected with ground squirrel hepatitis virus. Proc Natl Acad Sci USA 83: 4543–4546

    Article  PubMed  CAS  Google Scholar 

  • Mason WS, Seal S, Summers J (1980) Virus of Pekin ducks with structural and biological relatedness to human hepatitis B virus. J Virol 36: 829–836

    PubMed  CAS  Google Scholar 

  • Mason WS, Aldrich C, Summers J et al. (1982) Asymmetric replication of duck hepatitis B virus DNA in liver cells (free minus-strand DNA). Proc Natl Acad Sci USA 79: 3997–4001

    Article  PubMed  CAS  Google Scholar 

  • Mason WS, Halpern MS, England JM, Seal G, Egan J, Coates L, Aldrich C, Summers J (1983) Experimental transmission of duck hepatitis B virus. Virology 131: 375–384

    Article  PubMed  CAS  Google Scholar 

  • McLachlan A, Milich DR, Raney AK, Riggs MG, Hughes JL, Sorage J, Chisari FV (1987) Expression of hepatitis B virus surface and core antigens: influences of pre-S and precore sequences. J Virol 61: 683–780

    PubMed  CAS  Google Scholar 

  • Mehdi H, Kaplan MJ, Anlar FY, Yang X, Bayer R, Sutherland K, Peeples ME (1994) Hepatitis B virus surface antigen binds to apolipoprotein H. J Virol 68: 2415–2424

    PubMed  CAS  Google Scholar 

  • Melia WM, Wilkinson ML, Portmann BC, Johnson PJ, Williams R (1984) Hepatocellular carcinoma in the non-cirrhotic liver: a comparison with that complicating cirrhosis. Q J Med 53: 391–400

    PubMed  CAS  Google Scholar 

  • Milich DR, Jones JE, Hughes JL, Price J, Raney AK, McLachlan A (1990) Is a funtion of the secreted hepatitis B antigen to induce immunologie tolerance in utero? Proc Natl Acad Sci USA 87: 6599–6603

    Article  PubMed  CAS  Google Scholar 

  • Milich DR, Jones JE, Hughes JL, Maruyama T, Price J, Melhado I, Jirik F (1994) Extrathymic expression of the intracellular hepatitis B core antigen results in T cell tolerance in transgenic mice. J Immunol 152: 455–466

    PubMed  CAS  Google Scholar 

  • Miller RH, Marion PL, Robinson WS (1984a) Hepatitis B viral DNA-RNA hybrid molecules in particles from infected liver are converted to viral DNA molecules during an endogenous DNA polymerase reaction. Virology 139: 64–72

    Article  PubMed  CAS  Google Scholar 

  • Miller RH, Tran C-T, Robinson WS (1984b) Hepatitis B virus particles of plasma and liver contain viral DNA-RNA hybrid molecules. Virology 139: 53–63

    Article  PubMed  CAS  Google Scholar 

  • Molnar-Kimber KL, Summers JW, Mason WS (1984) Mapping of the cohesive overlap of duck hepatitis B virus DNA and of the site of initiation of reverse transcription. J Virol 51: 181–191

    PubMed  CAS  Google Scholar 

  • Molnar-Kimber KL, Jarocki-Witek V, Dheer SK, Vernon SK, Conley AJ, Davis AR, Hung PP (1988) Distinctive properties of the hepatitis B virus envelope proteins. J Virol 62: 407–416

    PubMed  CAS  Google Scholar 

  • Moriyama T, Guilhot S, Klopchin K, Moss B, Pinkert CA, Palmiter RD, Brinster RL, Kanagawa O, Chisari FV (1990) Immunobiology and pathogenesis of hepatocellular injury in hepatitis B virus transgenic mice. Science 248: 361–364

    Article  PubMed  CAS  Google Scholar 

  • Nassal M (1992) The arginine-rich domain of the hepatitis B virus core protein is required for pregenome encapsidation and productive viral positive-strand DNA synthesis but not for virus assembly. J Virol 66: 4107–4116

    PubMed  CAS  Google Scholar 

  • Negro F, Korba BE, Forzani B, Baroudy BM, Brown TL, Gerin JL, Ponzetto A (1989) Hepatitis delta virus (HDV) and woodchuck hepatitis virus (WHV) nucleic acids in tissues of HDV-infected chronic WHV carrier woodchucks. J Virol 63: 1612–1618

    PubMed  CAS  Google Scholar 

  • Neurath AR, Kent SB, Strick N, Parker K (1986) Identification and chemical synthesis of a host cell receptor binding site on hepatitis B virus. Cell 46: 429–436

    Article  PubMed  CAS  Google Scholar 

  • Neurath AR, Strick N, Sproul P (1992) Search for hepatitis B virus cell receptors reveals binding sites for interleukin 6 on the virus envelope protein. J Exp Med 175: 461–469

    Article  PubMed  CAS  Google Scholar 

  • Niederau C, Fischer R, Sonnenberg A, Stremmel W, Trampisch HJ, Strohmeyer G (1985) Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis. N Engl J Med 313: 1256–1262

    Article  PubMed  CAS  Google Scholar 

  • Niu J, Wang Y, Qiao M, Gowans E, Edwards P, Thyagarajan SP, Gust I, Locamini S (1990) Effect of Phyllanthus amarus on duck hepatitis B virus replication in vivo. J med Virol 32: 212–218

    Article  PubMed  CAS  Google Scholar 

  • Ou J-H, Rutter WJ (1987) Regulation of secretion of the hepatitis B virus major surface antigen by the preS-1 protein. J Vitrol 61: 782–786

    CAS  Google Scholar 

  • Ou J-H, Yeh CT, Yen TSB (1989) Transport of hepatitis B virus precore protein in to the nucleus after cleavage of its signal peptide. J Virol 63: 5238–5243

    PubMed  CAS  Google Scholar 

  • Pasquinelli C, Bhavani K, Chisari FV (1992) Multiple oncogenes and tumor suppressor genes are structurally and functionally intact during hepatocarcinogenesis in hepatitis B virus transgenic mice. Cancer Res 52: 2823–2829

    PubMed  CAS  Google Scholar 

  • Patzer EJ, Nakamura GR, Yaffe A (1984) Intracellular transport and secretion of hepatitis B surface antigen in mammalian cells. J Virol 51: 346–353

    PubMed  CAS  Google Scholar 

  • Patzer EJ, Nakamura GR, Simonsen CC, Levinson AD, Brands R (1986) Intracellular assembly and packaging of hepatitis B surface antigen particles occur in the endoplasmic reticulum. J Virol 58: 884–892

    PubMed  CAS  Google Scholar 

  • Petcu DJ, Aldrich CE, Coates L, Taylor JM, Mason WS (1988) Suramin inhibits in vitro infection by duck hepatitis B virus, Rous sarcoma virus, and hepatitis delta virus. Virology 167: 385–392

    PubMed  CAS  Google Scholar 

  • Popper H, Roth L, Purcell RH, Tennant BC, Gerin JL (1987) Hepatocarcinogenicity of the woodchuck hepatitis virus. Proc Natl Acad Sci USA 84: 866–870

    Article  PubMed  CAS  Google Scholar 

  • Potts RC, Sherif MM, Robesrton AJ, Gibbs JH, Brown RA, Beck JS (1981) Serum inhibitory factor in lepromatous leprosy: its effect on the pre-S-phase cell-cycle kinetics of mitogen-stimulated normal human lymphocytes. Scand J Immunol 14: 269–280

    Article  PubMed  CAS  Google Scholar 

  • Robinson WS, Miller RH, Marion PL (1987) Hepadnaviruses and retroviruses share genome homology and features of replication. Hepatology 7: 64S–73S

    Article  PubMed  CAS  Google Scholar 

  • Rosenthal N, Kress M, Gruss P et al. (1983) BK, viral enhancer element and a human cellular homology. Science 222: 749–755

    Google Scholar 

  • Schirmacher P, Held WA, Chisari FV, Yang D, Rogler CE (1992) Reactivation of insulin-like growth factor II during hepatocarcinogenesis in transgenic mice suggests a role in malignant growth. Cancer Res 52: 2549–2556

    PubMed  CAS  Google Scholar 

  • Schlicht HJ, Schaller H (1989) The secretory core protein of human hepatitis B virus is expressed on the cell surface. J Virol 63: 5399–5404

    PubMed  CAS  Google Scholar 

  • Schlicht HJ, Radziwill G, Schaller H (1989) Synthesis and encapsidation of duck hepatitis B virus reverse transcriptase do not require formation of core-polymerase fusion proteins. Cell 56: 85–92

    Article  PubMed  CAS  Google Scholar 

  • Seeger C, Ganem D, Varmus HE (1986) Biochemical and genetic evidence for the hepatitis B virus replication strategy. Science 232: 477–484

    Article  PubMed  CAS  Google Scholar 

  • Seifer M, Zhou S, Standring DN (1993) A micromolar pool of antigenically distinct precursors is required to initiate cooperative assembly of hepatitis B virus capsids in Xenopus oocytes. J Virol 67: 249–257

    PubMed  CAS  Google Scholar 

  • Sell S, Hunt JM, Dunsford HA, Chisari FV (1991) Synergy between hepatitis B virus expression and chemical hepatocarcinogens in transgenic in mice. Cancer Res 51: 1278–1285

    PubMed  CAS  Google Scholar 

  • Seto E, Yen TSB, Peterlin BM, Ou J-H (1988) Trans-activation of the human immunodeficiency virus long terminal repeat by the hepatitis B virus X protein. Proc Natl Acad Sci USA 85: 8286–8290

    Article  PubMed  CAS  Google Scholar 

  • Siddiqui A, Gaynor R, Srinivasan A, Mapoles J, Farr RW (1989) Transactivation of viral enhancers including long terminal repeat of the human immunodeficiency virus by the hepatitis B virus X protein. Virology 173: 764–766

    Article  Google Scholar 

  • Snyder RL, Summers J (1980) Woodchuck hepatitis virus and hepatocellular carcinoma. Cold Spring Harbor Conf Cell Proliferation 7: 447–458

    Google Scholar 

  • Spandau DF, Lee CH (1988) Transactivation of viral enhancers by the hepatitis B virus X protein. J Virol 62: 427–434

    PubMed  CAS  Google Scholar 

  • Standring DN, Ou J-H, Rutter WJ (1986) Assembly of viral particles in Xenopus oocytes: pre-surface-antigens regulate secretion of the hepatitis B viral surface envelope particle. Proc Natl Acad Sci USA 83: 9338–9342

    Article  PubMed  CAS  Google Scholar 

  • Standring DN, Ou J-H, Masiarz FR, Rutter WJ (1989) A signal peptide encoded within the precore region of hepatitis B virus directs the secretion of a heterogeneous population of e antigens in Xenopus oocytes. Proc Natl Acad Sci USA 85: 8405–8409

    Article  Google Scholar 

  • Summers J (1988) The replication cycle of hepatitis B viruses. Cancer 61: 1957–1962

    Article  PubMed  CAS  Google Scholar 

  • Summers J, Mason WS (1982) Replication of the genome of a hepatitis B—like virus by reverse transcription of an RNA intermediate. Cell 29: 403–415

    Article  PubMed  CAS  Google Scholar 

  • Tuttleman J, Pourcel C, Summers J (1986) Formation of the pool of covalently closed circular viral DNA in hepadnavirus infected cells. Cell 47: 451–460

    Article  PubMed  CAS  Google Scholar 

  • Tuttlemen J, Pugh J, Summers J (1986) In vitro experimental infection of primary duck hepatocyte cultures with duck hepatitis B virus. J Virol 58: 17–25

    Google Scholar 

  • Twu JS, Schloemer RH (1987) Transcriptional trans-activating function of hepatitis B virus. J virol 61: 3448–3453

    PubMed  CAS  Google Scholar 

  • Twu JS, Chu K, Robinson WS (1989) Hepatitis B virus X gene activated kB-like enhancer sequences in the long terminal repeat of human immunodeficiency virus 1. Proc Natl Aead Sci USA 86: 5168–5172

    Article  CAS  Google Scholar 

  • Unger T, Shaul Y (1990) The X protein of the hepatitis B virus acts as a transcription factor when targeted to its responsive element. EMBO J 9: 1889–1895

    PubMed  CAS  Google Scholar 

  • Wang GH, Seeger C (1992) The reverse transcriptase of hepatitis B virus acts as a protein primer for viral DNA synthesis. Cell 71: 663–670

    Article  PubMed  CAS  Google Scholar 

  • Wang GH, Seeger C (1993) Novel mechanism for reverse transcription in hepatitis B viruses. J Virol 67: 6506–6512

    Google Scholar 

  • Wang XW, Forrester K, Yeh H, Feitelson MA, Gu J-R, Harris CC (1994) Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity and associated with transcription factor ERCC3. Proc Natl Acad Sci USA 91: 2230–2234

    Article  PubMed  CAS  Google Scholar 

  • Will H (1991) The X-protein of hepatitis B virus. Facts and fiction. J Hepatol 13 Suppl 4: S56–S57

    Article  Google Scholar 

  • Will H, Reiser W, Weimer T, Pfaff E, Buscher M, Sprengel R, Cattaneo R, Schaller H (1987) Replication strategy of human hepatitis B virus. J Virol 61: 904–911

    PubMed  CAS  Google Scholar 

  • Wollersheim M, Debelka U, Hofschneider PH (1988) A transactivating function encoded in the hepatitis B virus X gene is conserved in the integrated state. Oncogene 3: 545–552

    PubMed  CAS  Google Scholar 

  • Yamamura K, Tsurimoto T, Ebihara T, Kamino K, Fujiyama A, Ochiya T, Matsubara K (1987) Methylation of hepatitis B virus DNA and liver-specific suppression of RNA production in transgenic mouse. Jpn J Cancer Res 78: 681–688

    PubMed  CAS  Google Scholar 

  • Yeh C-T, Liaw Y-F, Ou J-H (1990) The arginine-rich domain of hepatitis B virus precore and core proteins contains a signal for nuclear transport. J Virol 64: 6141–6147

    PubMed  CAS  Google Scholar 

  • Yokota T, Konno K, Chonan E, Mochizuki S, Kojima K, Shigeta S, De Clercq E (1990) Comparative activates of several nucleoside analogs against duck hepatitis B virus in vitro. Antimicrob Agents Chemother 34: 1326–1330

    PubMed  CAS  Google Scholar 

  • Zhou S, Standring DN (1991) Production of hepatitis B virus nucleocapsid like core particles in Xenopus oocytes: assembly occurs mainly in the cytoplasm and does not require the nucleus. J Virol 65: 5457–5464

    PubMed  CAS  Google Scholar 

  • Zhou S, Standring DN (1992) Hepatitis B virus capsid particles are assembled from core-protein dimer precursors. Proc Natl Acad Sci USA 89: 10046–10050

    Article  PubMed  CAS  Google Scholar 

  • Zhou S, Yang SQ, Standring DN (1992) Characterization of hepatitis B virus capsid particle assembly in Xenopus oocytes. J Virol 66: 3086–3092

    PubMed  CAS  Google Scholar 

  • Zoulim F, Saputelli J, Seeger C (1994) Woodchuck hepatitis virus X protein is required for viral infection in vivo. J Virol 68: 2026–2030

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Molecular and Experimental Medicine, The Scripps Research Institute, 10666 North Torrey Pines Road, La Jolla, CA, 92037, USA

    F. V. Chisari

Authors
  1. F. V. Chisari
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Molecular and Experimental Medicine, The Scripps Research Institute, 10666 North Torrey Pines Road, La Jolla, CA, 92037, USA

    Francis V. Chisari M.D. (Member, Head) (Member, Head)

  2. Division of Experimental Pathology, The Scripps Research Institute, 10666 North Torrey Pines Road, La Jolla, CA, 92037, USA

    Francis V. Chisari M.D. (Member, Head) (Member, Head)

  3. Department of Neuropharmacology, The Scripps Research Institute, 10666 North Torrey Pines Road, La Jolla, CA, 92037, USA

    Michael B. A. Oldstone M.D. (Member, Head) (Member, Head)

  4. Division of Virology, The Scripps Research Institute, 10666 North Torrey Pines Road, La Jolla, CA, 92037, USA

    Michael B. A. Oldstone M.D. (Member, Head) (Member, Head)

Rights and permissions

Reprints and permissions

Copyright information

© 1996 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Chisari, F.V. (1996). Hepatitis B Virus Transgenic Mice: Models of Viral Immunobiology and Pathogenesis. In: Chisari, F.V., Oldstone, M.B.A. (eds) Transgenic Models of Human Viral and Immunological Disease. Current Topics in Microbiology and Immunology, vol 206. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-85208-4_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-85208-4_9

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-85210-7

  • Online ISBN: 978-3-642-85208-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation